Baricitinib

Red

Brand Name(s):Olumiant

Indication:Severe atopic dermatitis

Rationale:1,2,3

Considered:Apr-21

Review Date:Apr-26

Comments:
Baricitinib is recommended as an option for treating moderate to severe atopic dermatitis in adults, only if the disease has not responded to at least 1 systemic immunosuppressant, such as ciclosporin, methotrexate, azathioprine and mycophenolate mofetil, or these are not suitable.